![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
KP Mayfield and LG D'Alecy
Department of Physiology, University of Michigan Medical School, Ann Arbor.
Previously an acute adaptation to hypoxia was induced by intermittent, severe hypoxia and this conditioned increase in survival time during subsequent hypoxia was blocked by naloxone. The current study further defined the opioid nature and the receptor type(s) involved in hypoxic adaptation by the use of (+)-naloxone (inactive isomer) and selective opioid antagonists. (+)-Naloxone failed to change significantly the survival times of hypoxic or sham conditioned mice during subsequent hypoxia. The selective opioid antagonists, 7-benzylidenenaltrexone, naltrindole, beta-funaltrexamine and norbinaltorphimine were administered subcutaneously before hypoxic or sham conditioning. The delta-1 and delta-2 selective antagonists, 7-benzylidenenaltrexone and naltrindole respectively, blocked the hypoxic conditioning-induced increase in survival time. The lowest effective 7-benzylidenenaltrexone dose was 3000-fold lower than the lowest effective naltrindole dose indicating that the acute adaptation to hypoxia was predominantly sensitive to delta-1 blockade. Neither the mu antagonist, beta- funaltrexamine, nor the kappa antagonist, norbinaltorphimine, significantly changed survival time in sham or hypoxic conditioned mice. These results support a delta-1 receptor mediated mechanism of acute adaptation to hypoxia.
This article has been cited by other articles:
|
|
 |
|
  M. Y. Song, C. F. Zwemer, S. E. Whitesall, and L. G. D'Alecy Acute and conditioned hypoxic tolerance augmented by endothelial nitric oxide synthase inhibition in mice J Appl Physiol, February 1, 2007; 102(2): 610 - 615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. Zwemer, M. Y. Song, K. A. Carello, and L. G. D'Alecy Strain differences in response to acute hypoxia: CD-1 versus C57BL/6J mice J Appl Physiol, January 1, 2007; 102(1): 286 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-C. Ma, H. Qian, F. Ghassemi, P. Zhao, and Y. Xia Oxygen-sensitive {delta}-Opioid Receptor-regulated Survival and Death Signals: NOVEL INSIGHTS INTO NEURONAL PRECONDITIONING AND PROTECTION J. Biol. Chem., April 22, 2005; 280(16): 16208 - 16218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Nicolini, C. Beghi, C. Muscari, A. Agostinelli, A. M. Budillon, I. Spaggiari, and T. Gherli Myocardial protection in adult cardiac surgery: current options and future challenges Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 986 - 993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. F. Bolling, V. Badhwar, C. F. Schwartz, P. R. Oeltgen, K. Kilgore, and T.-P. Su Opioids confer myocardial tolerance to ischemia: Interaction of delta opioid agonists and antagonists J. Thorac. Cardiovasc. Surg., September 1, 2001; 122(3): 476 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Jahania, J. A. Sanchez, P. Narayan, R. D. Lasley, and R. M. Mentzer Jr Heart preservation for transplantation: principles and strategies Ann. Thorac. Surg., November 1, 1999; 68(5): 1983 - 1987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-I Tsao, B. Ladenheim, A. M. Andrews, C. C. Chiueh, J. L. Cadet, and T.-P. Su Delta Opioid Peptide [D-Ala2,D-leu5]Enkephalin Blocks the Long-term Loss of Dopamine Transporters Induced by Multiple Administrations of Methamphetamine: Involvement of Opioid Receptors and Reactive Oxygen Species J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 322 - 331. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. E. J. Schultz, A. K. Hsu, and G. J. Gross Ischemic Preconditioning in the Intact Rat Heart Is Mediated by {delta}1- But Not µ- or {kappa}-Opioid Receptors Circulation, April 7, 1998; 97(13): 1282 - 1289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. J. Schultz, A. K. Hsu, H. Nagase, and G. J. Gross TAN-67, a delta 1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels Am J Physiol Heart Circ Physiol, March 1, 1998; 274(3): H909 - H914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Hepburn, P. J. Little, J. Gingras, and C. M. Kuhn J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1350 - 1356. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. E. J. Schultz, A. K. Hsu, and G. J. Gross Morphine Mimics the Cardioprotective Effect of Ischemic Preconditioning via a Glibenclamide-Sensitive Mechanism in the Rat Heart Circ. Res., June 1, 1996; 78(6): 1100 - 1104. [Abstract] [Full Text]
|
|
|
|
|
|
P. Sun and H. H. Loh Transcriptional Regulation of Mouse delta -Opioid Receptor Gene. ROLE OF Ets-1 IN THE TRANSCRIPTIONAL ACTIVATION OF MOUSE delta -OPIOID RECEPTOR GENE J. Biol. Chem., November 21, 2001; 276(48): 45462 - 45469. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
